Picture of Solventum logo

SOLV Solventum Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapSuper Stock

Annual cashflow statement for Solventum, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUSPROSPECTUSPROSPECTUS
Standards:
USG
USG
USG
USG
Status:FinalFinalFinalFinal
Net Income/Starting Line1,1381,4601,3431,346
Depreciation
Deferred Taxes
Non-Cash Items10911210124
Unusual Items
Other Non-Cash Items
Changes in Working Capital23467-202126
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities2,0262,2021,6791,915
Capital Expenditures-271-277-251-290
Purchase of Fixed Assets
Other Investing Cash Flow Items499-1-260
Sale/Maturity of Investment
Other Investing Cash Flow
Cash from Investing Activities228-278-253-230
Financing Cash Flow Items-1,766-1,960-1,460-1,552
Other Financing Cash Flow
Net Issuance / Retirement of Debt
Cash from Financing Activities-2,211-1,960-1,460-1,552
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash40-33-30133